Skip to main content
. 2016 Feb 4;114(5):582–589. doi: 10.1038/bjc.2015.474

Table 3a. Sensitivity, specificity, PPV, NPV, APV, TPV and RV of cytology for colposcopy outcomes (CIN2+) among women attending for a colposcopy within 12 months of their first invitation for screening.

Measure Vaccination N R Estimate (95% CI) P-value
Sensitivity high-grade dyskaryosis CIN2+ Unimmunised 807 604 74.85 (71.74, 77.72) 0.793
  Fully immunised 176 134 76.14 (69.32, 81.83)  
Specificity Neg/Border/LG CIN2+ Unimmunised 815 630 77.30 (74.30, 80.04) 0.950
  Fully immunised 303 233 76.90 (71.83, 81.29)  
PPV of high-grade dyskaryosis for CIN2+ Unimmunised 789 604 76.55 (73.47, 79.38) 0.002
  Fully immunised 204 134 65.69 (58.94, 71.86)  
NPV Neg/Border/LG for CIN2+ Unimmunised 833 630 75.63 (72.60, 78.42) 0.002
  Fully immunised 275 233 84.73 (80.00, 88.50)  
APV of Bl/LG for CIN2+ Unimmunised 759 179 23.58 (20.70, 26.73) 0.003
  Fully immunised 256 37 14.45 (10.67, 19.29)  
TPV of all colp for CIN2+ Unimmunised 1622 807 49.75 (47.32, 52.18) 0.000
  Fully immunised 479 176 36.74 (32.55, 41.15)  
RV of all colp for CIN2+ Unimmunised 1622 807 2.01 (1.92, 2.11) 0.000
  Fully immunised 479 176 2.72 (2.43, 3.07)  

Abbrevaitions: APV=abnormal predictive value; CI=confidence interval; CIN=cervical intraepithelial neoplasia; colp=colposcopy; NPV=negative predictive value; PPV=positive predictive value; RV=referral value; TPV=total predictive value.